Isoflavones are a class of flavonoids mostly available in leguminous plants where they play pivotal roles in plant–microbe interactions such as rhizobia–legume symbiosis and defense responses (Sugiyama, 2019). Isoflavones are involved in nodulation process in the leguminous plants by inducing the nodulation genes (Subramanian et al., 2006). They also act as a phytoalexins in plants, i.e., compounds produced by the plants during stress or pathogen attacks (Rípodas et al., 2013). Soybeans produce the maximum amount of isoflavones of all the leguminous crops, and they are the only significant dietary source of these groups of compounds (Kraszewska et al., 2007). Isoflavones have a similar size and chemical structure to the human estrogens that binds to both estrogen α and β receptors. Therefore, they are commonly referred to as “phytoestrogens” (Messina and Wood, 2008). Isoflavones are present in soybean as glycosylated form; however, their biological activity is from their aglycones. When soy foods are consumed, the soy isoflavones are converted to their aglycones by β-glucosidase from enteric bacteria (Tsuchihashi et al., 2008).

In recent years, scientists have been increasingly interested in isoflavones because of their potential health benefits. This can also be seen in the increased number of isoflavone containing nutritional health products in the market. Isoflavones have also been linked to cancer prevention, reduced alcohol intake, prevention of osteoporosis, and cardiovascular diseases (Dixon and Steele, 1999; Pandey et al., 2014). However, this does not mean that consuming isoflavone-rich foods is the ultimate solution to preventing diseases. In certain cases, isoflavones may be needed to consume in impossible quantities to achieve desired health benefits, although there may be some negative effects on human health. Therefore, it is imperative to increase the level of isoflavones in natural environment through metabolic engineering. Hence, understanding the molecular mechanism of isoflavone biosynthesis in various crops is important. This could pave the way to improved production of isoflavone and subsequently helps in the functional food production.

The general structure of isoflavone (Figure 1) is made up of a 3-phenylchromen-4-one backbone, with the rings denoted by the letters A, C, and B, beginning from the left (Figure 1). The position of phenyl ring in the structure of an isoflavone varies from that of a flavone, which is in position 2 in flavone but in position 3 in isoflavones (Figure 1). Although these compounds have structural similarities, they differ in their chemical behavior, and hence, the synthetic approaches for flavones cannot be used with isoflavones. Isoflavones belong to the large isoflavonoid family, which includes the following groups: isoflavones, isoflavans, isoflavanone, isoflavonols, isoflav-3-enes, α-methyldeoxybenzoins, rotenoids, pterocarpans, coumestans, 2-arylbenzofurans, 3-arylcoumarins, and coumaronochromones (Reynaud et al., 2005).

Isoflavones are known to have many effects on plant–microbe interactions, including control of nodulation, having an antifungal activity, and being precursors to phytoalexin (Yu et al., 2000). Phytoalexins act against both prokaryotic and eukaryotic microorganisms with their large spectrum of defense mechanisms (Paxton, 1981). In soybean, both the simple and complex derivatives of isoflavones act as phytoalexins. The main isoflavone phytoestrogens are genistein, daidzein, and glycitein (Křížová et al., 2019) (Figure 1). A rapid increase in the isoflavonoid levels in soybeans has been reported upon treatment with various pathogens (Graham, 1991, 1995; Lozovaya et al., 2004; Jeandet et al., 2013). Isoflavones also play a role in plant–environment interactions by mediating the symbiosis between plants and N₂ fixing bacteria. As plants could not use atmospheric N₂, the legumes develop symbiosis with the bacteria and used for its metabolism (Mulligan and Long, 1985). In respect to plant–microbe interaction, the rhizobia attracted by the root exudates move toward the legume roots through positive chemotaxis (Gaworzewska and Carlile, 1982; Caetano-Anolles et al., 1992; Compton et al., 2020). The Rhizobium genes are classified into two classes. Genes that determine the synthesis of exopolysaccharides (exo genes), lipopolysaccharides (lps genes), capsular polysaccharides of K antigens, and β-1,2-glucans (ndv genes) belong to the one class of genes involved in the synthesis of bacterial cell surface (Iyer and Rajkumar, 2017). The second class of genes comprises nodulation (nod) genes. Isoflavonoids from the plants act as key factor to induce the activation of rhizobial nodulation genes (Philips and Tsai, 1992; Liu and Murray, 2016; Ahmad et al., 2020) and require the participation of the transcriptional-activator protein NodD (Figure 2). In the first step, flavonoids excreted by the plant form a complex with the NodD protein, promoting the transcription of bacterial nod genes (Fisher and Long, 1992; Oldroyd et al., 2011; Del Cerro et al., 2019). In the second step, the bacterium produces lipooligosaccharide signals (Nod factors) (Spaink, 1992; Del Cerro et al., 2019) that cause various root responses through structural nod genes (Spaink et al., 1991). The role of isoflavonoids in root nodule formation is extensively studied in soybean by overexpression and RNAi-mediated gene silencing of IFS (isoflavone synthase) genes (Subramanian et al., 2005). This is not only specific to N₂ fixing bacteria, but it also plays an important role in symbiosis with mutualistic fungi (Figure 2). Isoflavones may promote spore germination, hyphal formation and growth, root colonization, and arbuscule formation within the root during the establishment of fungal symbiosis (Abdel-Lateif et al., 2012). The specific characteristics of utilization of atmospheric N₂ for their metabolism signify the legumes as important plant species for the development of soil quality and as an alternative for chemical N₂ fertilizers.

In the last few decades, the consumption of isoflavone-rich functional foods is highly recommended owing to the potential health protection against some aging-associated diseases such as cardiovascular disease, osteoporosis, hormone-related cancer, and cognitive impairment (Gilbert and Liu, 2013; Vitale et al., 2013; Chi et al., 2016) (Figure 3). Even though isoflavones present in a variety of plant-derived products such as cereals, potatoes, vegetables, and fruits, the richest sources in the human diet are soy-derived foods (Kraszewska et al., 2007). For instance, the US Food and Drug Administration announced in 1999 that consuming soy protein (25 g/day) (i.e., soy isoflavone) on a daily basis may decrease the risk of coronary heart disease by reducing the blood cholesterol content. Various clinical studies have revealed that isoflavone favorably lowers the risk of cardiovascular disease because of its estrogenic property (Yan et al., 2017; Nachvak et al., 2019). A systemic review that evaluated the impact of isoflavone diet on cardiovascular disease in 1,307 menopausal (n = 139) and postmenopausal (n = 1,268) women concluded that supplementation of soy isoflavone through diet reduces the cardiovascular risk by lowering the cholesterol and triglyceride plasma concentrations and also oxidative stress (Perna et al., 2016). The clinical study by Tikkanen and Adlercreutz (2000) suggested that dietary supplementation of isoflavone reduces low-density lipoprotein cholesterol concentrations and increased high-density lipoprotein concentration. However, the recent studies demonstrated that other constituents of soy, including proteins, fiber, and phospholipids, may play an important role in balancing the cholesterol profile than isoflavones. Some evidence hints that equol, a substance converted from soy isoflavones by the action of the intestinal microflora, seems to be playing a huge role in the reduction of cholesterol content (Nestel et al., 2004; Wu et al., 2007).

As the ovarian growth hormone (estrogen) has been linked to breast and uterine cancers, isoflavones with estrogenic effects may be used as an effective treatment to thwart breast and uterine cancer (Kumar et al., 2002). However, because of the estrogen-like properties of soy isoflavones, it may stimulate the development of estrogen-sensitive breast tumors in a few cases (Messina and Loprinzi, 2001); hence, understanding the action behind the intake of soy isoflavones and breast cancer reduction is still controversial. In contrast to these conclusions, epidemiologic results suggest that higher soy intake is linked to an approximately one-third lower incidence of breast cancer in Asian women (Wu et al., 2008). Other studies found that Japanese breast cancer patients have better survival rates than Western women, even after the diagnosis (Wu et al., 1996, 2002; Yamamoto et al., 2003). The anti–prostate cancer efficacy of isoflavones was elaborately reviewed by the Mahmoud et al. (2014). Both epidemiological and clinical studies revealed that dietary supplements containing isoflavones could be an effective alternative treatment for various hormonal disorders (Chen et al., 2019; Daily et al., 2019). One of such age-related hormonal diseases is osteoporosis, a bone loss disease that mostly occurs in women who are at menopause time. At the stage of menopause, the low secretion of ovarian hormone, i.e., estrogen, causes an imbalance between resorption and formation of new bone, and subsequent bone loss occurs (Hooper et al., 2010; Taku et al., 2011). The genistein is a well-known isoflavone phytoestrogen that plays an important role in prevention of osteoporosis by acting as an estrogen receptor modulator (Figure 3). Data from epidemiological studies revealed that the risk of osteoporosis has reduced in women who consume foods with high isoflavone content (Abdi et al., 2016).

A meta-analysis showed that supplementation of isoflavones greatly increases bone mineral density and decreases the marker of bone resorption, i.e., urinary deoxypyridinoline (Wei et al., 2012; Atcharaporn et al., 2014). They also found that there are numerous factors that could significantly influence the function of isoflavone on bone resorption and formation, such as menopausal status, dose of isoflavone, and intervention duration. Moreover, the menopausal period is associated with cardiovascular diseases due to low production of estrogen. As genistein has antiaging efficacy in various estrogen-dependent aging conditions, it can be used for cosmetic preparations to improve skin tone and reduce wrinkles and skin dryness (Wang et al., 2010; Geeta et al., 2019). The estrogenic effects of isoflavones, such as genistein and daidzein, were also used to improve the quality of sleep in Japanese adults (Cui et al., 2015). Furthermore, a previous study indicated that administration of soy isoflavones (daidzein, genistein, and glycetin) (20 mg/day) synergistically improved irritable bowel disease by combination with vitamin D in female patients (Jalili et al., 2016). Owing to its importance in natural processes and in human health, a plethora of researchers started to concentrate on the improved productions of isoflavones through metabolic engineering.

Isoflavonoids are limited primarily to the Leguminosae and a few other species. Isoflavones are synthesized via the phenylpropanoid pathway from which plants produce most of the secondary metabolites including lignin, flavone, flavonol, anthocyanin, and tannin, etc. Isoflavones are produced by using intermediate substrates of phenylpropanoid pathway, naringenin, and liquiritigenin, respectively. Naringenin is common in most plants, and other compounds of phenylpropanoid pathway, such as flavones, flavonol, and anthocyanin, are also derived from it (Figure 4). Another intermediate substrate of phenylpropanoid pathway, liquiritigenin, is produced by chalcone isomerase (CHI) and chalcone reductase (CHR). CHI is present in most plants, whereas CHR is specific for legumes. Isoflavone reaction comprised two steps. Cytochrome P450–mediated hydroxylation associated with 2,3-aryl migration of the B ring in 2S flavanones forms a 2-hydroxyisoflavanone using IFS (Figure 4). Then, this is dehydrated into the isoflavones (genistein and daidzein) through the natural reaction catalyzed by specific dehydratase enzyme (Kochs and Grisebach, 1986; Hakamatsuka et al., 1990, 1998).

Generally, genes on the phenylpropanoid pathway are known to be triggered by environmental stresses (nutrient deficiency, excessive heat, and pathogen attack, etc.) through developmental and tissue-specific regulation (Dixon and Paiva, 1995). Many of the upstream phenylpropanoid pathway enzymes, namely, phenylalanine ammonia lyase (PAL), cinnamate 4-hydroxylase (C4H), p-coumaroyl-CoA (4CL), CHS, and CHI, have been well characterized. PAL catalyzes the deamination of phenylalanine to produce trans-cinnamic acid, which is then transformed to p-coumaric acid through an oxidation reaction catalyzed by C4H. After 4CL activates the thio esterification, p-coumaroyl-CoA directed into the branched pathway resulted in the production of lignins and flavonoids. C4H belongs to the CYP73 family of the large group of cytochrome P450 monooxygenases (Teutsch et al., 1993). Cytochrome P450 monooxygenases are playing a role in the biosynthesis of a wide range of metabolites in plants (e.g., fatty acids, phenylpropanoids, alkaloids, and terpenoids) and detoxification of herbicides and pesticides (Chapple, 1998). The accumulation of chalcone in plant tissue is rare. CHI catalyzes the stereospecific isomerization of chalcones into corresponding (2S)-flavanones, naringenin, and liquiritigenin (Figure 4). Even in the absence of CHI, chalcones can be spontaneously isomerized to form (2S)-flavanones, at a slower rate (Jez et al., 2000). CHR, which is not present in nonlegume species, belongs to the aldo-keto-reductase superfamily and is involved in the synthesis of 6′-deoxychalcone, which is the precursor for daidzein. Among the genes, flavanone-3-hydroxylase (F3H) uses naringenin as a substrate; therefore, it competes with IFS for the formation of isoflavones. The phenylpropanoid pathway genes and their roles are elaborated below.

As the consumption of isoflavones is associated with a variety of health benefits to the humans, several attempts were made to develop soybeans that accumulate much higher levels of isoflavones than in wild-type seed. Generally, the isoflavone contents in G. max (soybean) were improved through metabolic engineering of the complex phenylpropanoid biosynthetic pathway. In a first study, the phenylpropanoid pathway genes were activated by expressing the maize CRC fusion gene, resulting in a decrease in genistein and the increase in daidzein levels with a marginal increase in total isoflavone levels (Grotewold et al., 1998). Cosuppression of flavanone 3-hydroxylase to block the anthocyanin branch of the pathway, in conjunction with CRC expression, resulted in higher levels of isoflavones (Yu et al., 2003). The use of transcription factor–driven gene activation combined with the suppression of a competing pathway resulted in increased isoflavone accumulation in soybean seeds. These high isoflavone soybeans could be used to make soy foods with greater health benefits to consumers.

The regulation of isoflavone biosynthesis is carried out by multiple genes and complex metabolic pathways. In order to understand the specific functions/regulation of the genes involved in the phenylpropanoid pathway for isoflavone biosynthesis, the overexpression or gene-silencing methods of specific genes can be carried out. Hence, Subramanian et al. (2005) have studied the RNAi-mediated gene silencing of GmIFS genes in the soybean. The study resulted in the reduced level of isoflavone accumulation in the gene silenced plants compared to control (Table 2). In another study, overexpression of CHS6 and IFS2 genes resulted in the reduced level of isoflavones and increased level of phenolic compounds (Lozovaya et al., 2007). Jiang et al. (2010; 2014) explored the negative regulation of F3H and GmFNSII genes by the RNAi-mediated gene silencing studies. Previously, the gene silencing of GmFNSII resulted in the increased accumulation of genistein in soybean hairy roots (Jiang et al., 2010). Later, RNAi-mediated silencing of both genes (F3H and GmFNSII) was found to increase accumulation of isoflavones such as daidzein and genistein (Jiang et al., 2014) (Table 2).

Overexpression of GmIMaT1, GmIMaT3 genes significantly increased the different forms of isoflavones such as aglycones, glucosides, and malonylates, but in knockdown of the genes, the isoflavone levels were reduced drastically (Ahmad et al., 2017) (Table 2). Zhang et al. (2020) have used a new methodology for the regulation of isoflavone biosynthetic genes by introducing CRISPR/Cas9-mediated targeting mutation of multiple genes (GmF3H1, GmF3H2, and GmFNSII-1) in soybean. The T3 generation of triple gene mutants produced increased levels (twice the amount) of genistein compared to controls. The increased isoflavone content also leads to the enhanced resistance to soybean mosaic virus infections (Zhang et al., 2020). Recently, Nguyen et al. (2020) found that overexpression of GmCHI1A was found to increase higher levels of both genistein and daidzein in T2 generations, but previously, Zhou et al. (2018) reported that it can increase the daidzein content alone (Table 2).

Not only changing the specific genes in the phenylpropanoid pathway can notably increase/decrease isoflavone content but also the transcription factors. Therefore, the identification and application of transcription factors, particularly for the isoflavone pathway, may significantly resolve this problem (Yu and McGonigle, 2005; Chu et al., 2017). The transcription factors of the Myeloblastosis (MYB) family play crucial roles in the regulation of isoflavone biosynthesis. Yi et al. (2010) demonstrated through the functional genomic approach that GmMYB176 (R1 MYB protein) regulates CHS8 expression and affects the synthesis of isoflavonoids in soybean. In this study, cotransfection analysis with Arabidopsis leaf protoplast resulted that GmMYB176 transactivate the CHS8 promoter with maximum activity. As a result of transient expression in soybean embryo protoplast, after 48 h, the endogenous transcript levels were increased up to 149-fold. Subcellular localization assay indicates that GmMYB176 is a nuclear protein. RNAi-mediated gene silencing of GmMYB176 in hairy roots resulted in reduced levels of isoflavonoids, but overexpression of GmMYB176 did not significantly increase the levels of CHS8 transcript (Yi et al., 2010) (Table 2). Liu et al. (2013) reported that soybean MYB transcription factor GmMYB39 was potentially regulating the isoflavone biosynthesis. GmMYB39 that contained N-terminal R2R3 repeats corresponds to DNA-binding domains of plant MYB-type proteins, which were highly conserved among R2R3-MYB proteins. Quantitative reverse transcriptase–polymerase chain reaction results revealed that overexpression of GmMYB39 was found to be varied in different parts of the plants. Interestingly, the higher level of transcripts was found in flowers, and lower level in the pods. GmMYB39 overexpression in hairy roots resulted in drastic reduction of the transcript levels of PAL, C4H, CHS, 4CL, and CHR. However, the transcript level of IFS was slightly increased, whereas there is no change in CHI expression between overexpressed hairy roots and control roots. Overall, this report suggests that GmMYB39 is involved in the inhibition role in regulation of isoflavone biosynthesis in soybean (Table 2).

Yan et al. (2015) found that R2R3-MYB transcription factor GmMYB100 is involved in soybean isoflavone biosynthesis. Generally, GmMYB100 is expressed in flowers, leaves, and immature embryo, but its level will decrease after pod ripening. The subcellular localization study found the nuclear localization of GmMYB100. Initially, yeast functional assay revealed the transactivation ability of GmMYB100, but the bioinformatics analyses suggested its negative role in flavonoid biosynthesis. Finally, the overexpression of GmMYB100 reduced transcript levels of transgenic hairy roots and Arabidopsis and reduced flavonoid and flavonol productions, respectively, whereas the RNAi-mediated silencing resulted in the higher level of transcripts of six flavonoid related genes and accumulated higher level of flavonoids in transgenic hairy roots (Table 2). Similarly, Genome-Wide Association Study for the identification of SNPs related to isoflavone concentration in soybean found that another R2R3-MYB transcription factor GmMYB29 is significantly involved in regulation of isoflavone biosynthesis (Chu et al., 2017). The subcellular localization analysis found that GmMYB29 was located in the nucleus. It is found to be activated IFS2 and CHS8 gene promoters by the transient gene expression assays. Furthermore, GmMYB29 overexpression and RNAi-mediated silencing in soybean hairy roots resulted in 1.6- to 3.3-fold increase and isoflavone contents in twofold decrease (Chu et al., 2017). Zhao et al. (2017) explored the role of GmMYBJ3 in regulation of the isoflavone biosynthetic pathway. This result suggests that GmMYBJ3 can activate the CHS8 and CHI1A genes; therefore, increased accumulation of isoflavones has been witnessed (Zhao et al., 2017).

Gupta et al. (2017) have identified miRNAs in the regulation of isoflavone biosynthesis in two contrast genotypes of soybean. In silico analysis identified 31 new miRNAs along with the 245 putative target genes from the seed-specific ESTs. Based on the Kyoto Encyclopedia of Genes and Genomes pathway analyses, five genes (Gma-miRNA12, Gma-miRNA24, Gma-miRNA26, Gma-miRNA28, and Gma-miRNA29) were found to be involved in isoflavone biosynthesis, among which Gma-miRNA26 and Gma-miRNA28 and their corresponding genes (Glyma.10G197900 and Glyma.09G127200) exhibited their direct relationship with the isoflavone content of the soybean (Table 2). Bian et al. (2018) identified that GmMYB133 (CCA1-like MYB) positively regulates isoflavone biosynthesis in soybean. Overexpression of GmMYB133 has led to the expression of two important isoflavonoid biosynthetic genes such as GmIFS2 and GmCHS8 and increased total isoflavonoid contents in the hairy roots. Furthermore, the protein–protein interaction results revealed that it can form heterodimers with another isoflavone regulator GmMYB176 and homodimers with another GmMYB133 (Bian et al., 2018).

Sarkar et al. (2019) found that GmMYB102, GmMYB280, and GmMYB502 were the potential transcription factors that can activate the promoters of the CHS gene (GmCHS8) and the IFS genes (GmIFS1 and GmIFS2) in the isoflavone biosynthetic pathway by hairy root transformation assay. They have assessed the functional regulatory role of these genes by hairy root transformation assay, resulting in increased accumulation of isoflavones (two- to fourfold) in the three MYB overexpressing lines compared to vector control (Table 2). Anguraj Vadivel et al. (2019) have identified that GmMYB176 (R1 MYB transcription factor) activates the CHS8 gene and regulates the isoflavonoid biosynthesis in soybean. They have identified 25 metabolic genes and six metabolites by the targeting approach that is differentially regulated during overexpression and silencing of GmMYB176 in soybean hairy roots (Table 2).

Jahan et al. (2020) have identified that GmMYB29A2 transcription factor positively regulates glyceollin biosynthesis in soybean. Glyceollins are pathogen-inducible defensive metabolites (phytoalexins) that play important roles in pathogen defense (Jahan et al., 2019). Overexpression of GmMYB29A2 increased the expression of GmNAC42-1, GmMYB29A1, and glyceollin biosynthesis genes and metabolites, whereas RNAi-mediated gene silencing had opposite effects. Previously, Jahan et al. (2019) have studied the role of GmNAC42-1 in activation of glyceollin biosynthesis by expression analysis. In this study, they confirmed the positive regulation of GmMYB29A2 that leads to the increased conversion of isoflavonoids into the glyceollin and thus develops resistance against Phytophthora sojae (Jahan et al., 2020). Matsuda et al. (2020) studied the diurnal metabolic regulation of isoflavones and soy saponins in soybean roots. The transcriptome and metabolite analysis of soybean plants at 6-h intervals for 48 h in a 12-h light–12-h dark condition. In the root tissues, isoflavone and soy saponin biosynthetic genes showed opposite patterns; the former are highly expressed in the day, whereas the latter are strongly triggered at night. GmMYB176, which encodes an isoflavone biosynthesis transcription factor, was upregulated from ZT0 (6:00 A.M.) to ZT6 (12:00 A.M.), accompanied by the stimulation of isoflavone biosynthetic genes at ZT6 (Matsuda et al., 2020). Recently, Vadivel et al. (2021) have found that the RNAi silencing of transcription factor GmbZIP5 reduced the isoflavone accumulation in hairy roots. Furthermore, the co-overexpression of GmMYB176 and GmbZIP5 enhanced the accumulation of multiple isoflavonoids such as glyceollin, malonyl glycitin, isowighteone, and O-methyl hydroxyl isoflavone in soybean hairy roots. An ample of studies in the regulation of isoflavone biosynthetic genes provided the role of key players in soybean isoflavone biosynthesis, which could be useful for the development of soybean with desired level of isoflavones.

Epidemiologic studies show that a high intake of soybean-derived foods is linked to a low incidence of hormone-related cancers, menopausal symptoms, osteoporosis, menopausal symptoms, and cardiovascular diseases. Furthermore, metabolic engineering of isoflavonoids in common nonlegume vegetables, grains, and fruits to increase dietary intake of these compounds has piqued researchers’ interest (Dixon and Sumner, 2003; McCue and Shetty, 2004; Deavours and Dixon, 2005).

Initially, in a monocot cell system, introduced expression of a transcription factor controlling anthocyanin pathway genes was successful in the production of genistein in the presence of the IFS gene (Yu et al., 2000). The genistein produced in tobacco, Arabidopsis, and maize cells is present in conjugated forms, indicating that endogenous enzymes were capable of recognizing genistein as a substrate. Introducing foreign IFS gene in Arabidopsis seedlings (Jung et al., 2000), tobacco petals, and maize cells in which the phenylpropanoid pathway was activated by C1 and R transcription factors resulted in successful accumulation of genistein (Yu et al., 2000), demonstrating that heterogeneous IFS can use flavanone intermediates as substrates. However, in these cases, the genistein levels were two- to threefold lesser than in soybean seeds (Dixon and Ferreira, 2002). The higher genistein content in transgenic tobacco petals compared to leaves was thought to be due to a more active phenylpropanoid pathway leading to anthocyanin biosynthesis in petals, which also increased the level of intermediates available to IFS (Yu et al., 2000). The low transgene expression is not the cause of low genistein production in the tobacco leaves. The IFS mRNA was actually detected at a higher level in the leaves than in the flowers of tobacco transformants, and IFS protein and enzyme activity were also confirmed in the leaves. Thus, the poor genistein synthesis is most likely due to a lack of naringenin substrate. As IFS can fight for naringenin in tobacco flowers and Arabidopsis leaves, channeling might be the cause of unavailability.

Conversely, Liu et al. (2002) produced transgenic Arabidopsis with significantly increased genistein accumulation (31–169 nmol/g Fresh weight (FW)), but soybean IFS was introduced into Arabidopsis tt6/tt3 mutant in which the expression of F3H and another flavonol/anthocyanin enzyme dihydroflavonol reductase was decreased (Liu et al., 2002). As F3H and IFS both use naringenin as a substrate, the researchers hypothesized that the competition for intermediate availability between IFS and other enzymes was a limiting factor for a genistein biosynthesis in genetically modified plants. Furthermore, blocking a competing branch pathway may be a useful method to promote genistein biosynthesis (Liu et al., 2007). UV-B irradiation of Arabidopsis transformants expressing the soybean IFS gene resulted in a 2.5-fold increase in genistein accumulation. Increased levels of UV absorption and anthocyanins in IFS-transformed plants depict the higher activity of phenylpropanoid pathway (Yu et al., 2000; Liu et al., 2002). Deavours and Dixon (2005) have improved the genistein production for up to 50 nmol/g FW by constitutively expressing MtIFS1 in the alfalfa plants. Genistein levels of this study are much higher than previous studies (Jung et al., 2000; Yu et al., 2000; Liu et al., 2002). Even though MtIFS1 expresses all the tissues in plants, genistein accumulation was specific to the leaves. Apart from the genistein, the plants also accumulated other isoflavones such as daidzein and formononetin in response to the UV-B treatments.

Tian and Dixon (2006) have improved the isoflavone metabolism by introducing the CHI, CHS, and CHI/CHS fusion protein into the tobacco plants. High-performance liquid chromatography (HPLC) analysis results showed the accumulation of genistein in both IFS- and IFS/CHI-transformed plants, but not in vector control and CHI plants. In transgenic tobacco, lettuce, and petunia, both overexpression and antisense suppression were used to control the expression of multiple genes essential enzymes in the flavonoids/isoflavonoids pathway (Liu et al., 2007) (Table 1). The introduction of soybean IFS (GmIFS) into these plants, which lack this leguminous enzyme and therefore do not produce isoflavonoids naturally, resulted in genistein biosynthesis in tobacco petals, petunia leaves and petals, and leaves of lettuce. In tobacco, when antisense suppression of F3H and overexpression of GmIFS were done simultaneously, the yield of genistein increased prominently. In addition, overexpression of PAL also led to an enhanced genistein production in tobacco petals and lettuce leaves in the presence of IFS than in the plants that overexpressed only IFS (Liu et al., 2007). Similarly, Misra et al. (2010) transformed the IFS gene from the medicinal plant P. corilyfolia (PcIFS) into the tobacco. Overexpression of PcIFS resulted in the higher accumulation of isoflavones in the tobacco petals (Table 1).

As rice is an important crop and staple food for half of the world population, recently it caught extensive attention as bioreactors for the production of therapeutic compounds and proteins. Although production of isoflavones in rice plants was performed by several researchers, Shin et al. (2006) for the first time in rice plants have transformed maize C1 and R-S regulatory genes for the production of isoflavones. The expression of transgenes is restricted to endosperm under the control of a rice prolamin gene promoter. The transformed plants showed several phenotypic variations such as changes in pericarp color, chalky endosperm, and opaque kernel. HPLC analysis showed that several types of isoflavones accumulated in the transgenic kernels. Among which taxifolin, 3′-O-methyl taxifolin and 3′-O-methyl quercetin were identified through liquid chromatography (LC)–tandem mass spectrometry (MS/MS) analysis (Table 1). Furthermore, they have confirmed the accumulation of isoflavones in the layers of endosperm by the florescence labeling. At the same time, Sreevidya et al. (2006) have introduced the GmIFS gene into the rice plants for the production of isoflavones under the control of CaMV35S promoter. The genistein accumulated as a glycosylated form in the rice plants. Rhizobia study for the nod gene expression confirms the accumulation of isoflavones inducing the nod genes in varied degrees.

Introduction of five biosynthetic genes (OsPAL, OsC4H, Os4CL, OsCHS, and OsCHI) with the endosperm-specific GluB-1 promoter into one vector has been done through Agrobacterium-mediated transformation (Ogo et al., 2013). As multiple-expression cassette is quite large, some of the parts were deleted in a few plants; as a result, none of the transgenic plants did not express all the five genes. Generally, plants were found to have one to four expression cassettes. The resulted plant that is lacking either OsPAL or OsCHS gene does not accumulate naringenin, but has both genes accumulating naringenin in the seeds. Furthermore, these selected genes were transformed exclusively with embryo- and endosperm-specific 18 kDa oleosin and GluB-1 promoters for the identification of isoflavone localization. LC-MS analysis revealed the accumulation of naringenin and some flavones. Also the expression of additional genes for flavone (PoFNSI/GmFNSII), isoflavone (GmIFS), and flavonol (AtF3H/AtFLS) has resulted in the accumulation of kaempferol, genistein derivatives, quercetin, chrysoeriol, and tricin, etc. (Table 1). Song et al. (2013) aimed to generate colored rice seeds and increased accumulation of isoflavone that expressed maize-Lc gene under the control of endosperm-specific rice glutelin Gt-1 promoter. As a result, the transgenic rice was found to be with dark color and the total isoflavone content also increased. Expression of two soybean isoflavone synthases (SpdIFS1 and SpdIFS2) under the control of endosperm-specific 26-kDa globulin promoter in rice varieties accumulated a higher level of genistein in seeds (Sohn et al., 2014). As the two rice varieties has different seed color (black and normal white), the accumulation of isoflavone was also found to be varied. The white variety (103 μg/g) of transgenic rice has accumulated more genistein than black variety (87 μg/g) (Table 1).

In an attempt of isoflavone biosynthesis in tomato, Shih et al. (2008) have transformed soybean IFS (GmIFS) gene under the control of the CaMV35S promoter. The transgenic plants accumulated genistein in a tissue-specific manner. The LC-MS analysis has found that substantial amount of genistein has been accumulated in the leaves, whereas the little amount has been accumulated in fruit peel. Although Brassica napus, a nonleguminous oil crop, produced phenylpropanoids and flavonoids but not isoflavones because of the absence of the IFS gene. Incorporation of exogenous GmIFS2 showed the accumulation of genistein in the leaves of transgenic plants up to 0.72 mg/g dry weight (Li et al., 2011) (Table 1). With the aim of increased accumulation of genistein in transgenic tobacco, Pandey et al. (2014) has engineered the tobacco with the coexpression of GmIFS and transcription factor AtMYB12. The transgenic plants accumulated higher levels of flavonols and genistein conjugates compared to control plants. Gou et al. (2016) have transformed different combinations of isoflavone pathway genes (CHS, CHI, IFS, and F3H) in Medicago truncatula for the increased accumulation of isoflavones and proanthocyanidins. Downregulation of MtF3H in combination with overexpression of GmIFS1, GmCHS7, and GmCHI1A was found to be more effective in elevated accumulation of isoflavones, flavones, and proanthocyanidins. Recently, Malla et al. (2021) have transformed GmIFS into onion (Allium cepa L.) for the accumulation of genistein in transformed onion plants through both biolistic gene transfer and Agrobacterium-mediated gene transfer methods. The results showed that a higher level of genistein was accumulated in biolistic gene transfer (62.65 nM/g FW) than Agrobacterium-mediated gene transfer method. Thus, introducing the transcription factor for the positive or negative regulation of the isoflavone biosynthesis proved the efficiency of transcription factors, suggesting that it can be utilized for both leguminous and nonleguminous plants for the regulation of isoflavone biosynthesis.

Isoflavones have important roles in plants, environment, humans, and other animals with their compatible chemical structures. Their general occurrence in the soybean and its applications in various diseases, as we highlighted, necessitated the detailed understanding of the metabolic engineering process and the regulation of isoflavone biosynthesis in the plants. We have provided an overview of the isoflavone biosynthesis through metabolic engineering in various crop plants. The recent progression in the identification and characterization of important enzymes in the isoflavone biosynthetic pathway has helped to improve the level of isoflavones in plants. However, as phenylpropanoid pathway is a complex pathway for isoflavone biosynthesis, simultaneous engineering of multiple genes and understanding the crosstalk between pathways are important. That helps us to understand the role of a specific branch of the pathway in the biosynthesis of isoflavones and other secondary metabolites. The isoflavone-level variation is a complex mechanism regulated by various genetic and environmental factors. Transcriptional regulation of isoflavone biosynthesis occurs by modifying the transcription factors such as MYBs either to increase or decrease the level of isoflavones in soybean (Yi et al., 2010; Yan et al., 2015; Bian et al., 2018; Jahan et al., 2020). In addition to that, posttranslational regulation of isoflavone biosynthesis through ubiquitination and SUMOylation processes has become necessary tools for clear understanding of how isoflavones can be produced. Likewise, synthetic metabolic engineering technologies, such as a multigene expression vector system (CRISPR/cas9)–based system, should be used efficiently for expression and regulation of isoflavone biosynthetic genes in a precise manner (Zhang et al., 2020). With the deep understanding of the isoflavone biosynthetic pathway, novel technologies in metabolic engineering and synthetic metabolic engineering will decipher light on the regulation of complex metabolic networks and can produce biofortified crops with required isoflavone levels to meet better human health.

SIS and SP conceived the review and wrote the manuscript and made a critical revision of the review. YJO, HJK, WSC, and YSC performed the literature search. SP and YJO prepared figures and tables. All authors contributed to the article and approved the submitted version.

YJO was employed by the company Institute for Future Environmental Ecology Co., Ltd., Jeonju, South Korea. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.